<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Lipids. Author manuscript; available PMC 2007 April 5. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Lipids. 2007 February ; 42(1): 69&#226;&#8364;&#8220;76. <br />  <br />  <br />                            Synthetic Lethal Interactions Involving Loss Yeast ERG24- <br />                            Sterol C-14 Reductase Gene. <br />  <br />                            M. Shah Alam Bhuiyan1, James Eckstein2, Robert Barbuch2, Martin Bard1,* <br />                            1Indiana University-Purdue University Indianapolis, Biology Department, 723 West Michigan Street, <br />                            Indianapolis, 46202. <br />                            2Department Drug Disposition, Eli Lilly <span id='am-29' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-30' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="AMP" datatype="xsd:string"></span>amp</span>; , Lilly Corporate Center, Indianapolis, Indiana 46285 <br />  <br />                            Abstract <br />                                  ERG2 ERG24 yeast sterol biosynthetic genes targets morpholine antifungals. <br />                                  ERG2 ERG24 encode C-8 sterol isomerase C-14 reductase, respectively. ERG2                                  considered non-essential gene viability ERG24 dependent genetic background, <br />                                  type medium, CaCl2 concentration. demonstrate erg2 erg24 mutants viable <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  deletion consortium background lethal combined haploid strain. <br />                                  erg2erg24 double mutant suppressed mutations <span id='am-12' about='obo:IMR_0001359' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001362'><span id='am-13' property="rdfs:label" content="sphingolipid" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0001359" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="CHEBI:26739" datatype="xsd:string"></span>sphingolipid</span> gene ELO3                                  ELO2.  suppression occurs rich synthetic complete medium.                                  demonstrate suppressed elo3erg2erg24 does sterol composition markedly <br />                                  different erg24. genetic analysis indicates erg24 combined mutations <br />                                  erg6 erg28 synthetically lethal combined mutations erg3 weakly viable. <br />                                  results suggest novel sterol intermediates likely contribute synthetic lethality <br />                                  observed investigation. <br />  <br />  <br />                            Introduction <br />                                              synthesis <span id='am-7' about='obo:IMR_0200096' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0200096" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C01724" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="Lanosterol" datatype="xsd:string"></span>lanosterol</span> committed step yeast sterol biosynthesis. yeast <br />                                              ERG24 gene encodes C-14 reductase required complete C-14 demethylation                                              lanosterol. gene cloned disrupted investigators demonstrated                                              C-14 reductase enzyme essential viability (1,2). Originally, erg24 mutants                                              lethal wildtype genetic backgrounds viable genetic backgrounds containing <br />                                              mutations elo2/fen1 (1,2). Mutations ELO2/FEN1 (3) gene result resistance NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              morpholine, fenpropimorph (1,2). morpholines inhibit C-8 isomerase                                              C-14 reductase encoded ERG2 ERG24, respectively (4,5) possibly indicating common <br />                                              target site enzymes uncharacterized protein-protein interaction  <br />                                               resistance fenpropimorph mutation FEN1 results tolerance  <br />  <br />                            *Corresponding author. Mailing address: Martin Bard, IUPUI, Biology Department, 723 West Michigan Street, Indianapolis, 46202. <br />                            e-mail: mbard@iupui.edu <br />                            Abbreviations: <br />                            CSM <br />                                             synthetic complete media <br />  <br />                            GC <br />                                             <span id='am-1' about='obo:IMR_0001720' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0001720" datatype="xsd:string"></span><span id='am-3' property="obo:IAO_0000115" content="The vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure." datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="MeSH:D005740" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="gas" datatype="xsd:string"></span>gas</span> chromatography <br />  <br />                            PCR <br />                                             polymerase chain reaction <br />  <br />                            YPAD <br />                                             yeast extract, peptone, <span id='am-41' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-42' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>adenine</span>, dextrose <br />                             Shah Alam Bhuiyan et al.                                                                                       Page 2 <br />  <br />  <br />                                                accumulation sterol intermediate, ergosta-8,14-dienol. Lorenz Parks able                                                construct deletion mutation ERG24 gene viable fen1 background <br />                                                (1). Similarly, Ladeveze et al. demonstrated ERG24 mutants viable fen1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                background (6). Subsequent work Baudry et al. demonstrated erg24 mutants                                                suppressed mutations elo3/sur4 (7). ELO2/FEN1 ELO3/SUR4 encode enzymes                                                involved sphingolipid synthesis components fatty acid elongation                                                elongates C16/C18 C24/C26 (3). analyses indicated erg24 mutants                                                grown genetic backgrounds (wildtype ELO2 ELO3) synthetic complete <br />                                                rich medium containing Ca+2 Mg+2 (8,9). replacement ergosterol                                                ergosta-8,14-dienol lethal itself requires adequate level ions.                                                C-8 isomerase C-14 reductase enzymatic reactions sensitive                                                morpholine antifungals, overexpression non-essential gene, ERG2 does lead                                                fenpropimorph resistance overexpression essential gene, ERG24 does (10). <br />                                                erg2 mutants generally isolated non-essential various genetic <br />                                                backgrounds, single erg2 mutant isolate FL100 wildtype genetic background                                                demonstrated lethal suppressible mutations ELO2 ELO3 gene <br />                                                (11,3). <br />  <br />                                                Previously, demonstrated ERG24 essential gene wildtype Y294 genetic <br />                                                background (10) erg24 mutant strain produced deletion consortium project using <br />                                                S288C wildtype genetic background clearly indicates viable erg24 mutants occur <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                genetic backgrounds containing ELO2 ELO3 mutations. study                                                demonstrate various synthetic lethal interactions occur erg24 strain derived <br />                                                deletion consortium genetic (S288C) background. <br />  <br />                               MATERIALS METHODS <br />                               Strains, media, growth conditions. <br />                                                Yeast strains used study derived W303; SCY325 strain (MAT&#206;&#177;, ade2-1, <br />                                                his3-11,15, leu2-3,112, trp1-1, ura-3-1) SCY328 (MATa, ade2-1, his3-11,15, leu2-3,112, <br />                                                trp1-1, ura-3-1) wildtype laboratory strains used generate ergosterol mutant <br />                                                strains erg24. erg24 strain obtained deletion consortium (12)                                                construction ergosterol deletion strains erg2, erg3, erg4, erg5, erg6, erg28 <br />                                                published previously (13). deletion mutant strains elo2 elo3 generated <br />                                                homologous recombination PCR products (14) plasmid containing selectable <br />                                                marker genes (15) oligonucleotides containing gene specific sequences. elo2                                                elo3 strains derived W303 background isolated elo2::TRP1 elo3::TRP1 <br />                                                disruptions using forward reverse primers (ELO2fwd: 5&#226;&#8364;&#8482;- <br />                                                ATGAATTCACTCGTTACTCAATATGCTGCTCCGTTGTTCGAGCGTTATCCCCAAC <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                TTCATTGGCGGGTGTCGGGGCTGGC -3&#226;&#8364;&#178; ELO2rev: 5&#226;&#8364;&#178;- <br />                                                TAGGAACGTTTTTCAAGTCAACGTTAACATACTCATTAACCTTTGCGGGAACAC <br />                                                CGCCGTTTGCCGATTTCGGCCTATTG -3&#226;&#8364;&#178; elo3::TRP1 ELO3fwd: 5&#226;&#8364;&#178;- <br />                                                AGCTTACTTCTAGTTTATTTATTCGGCTTTTTTCCGTTTGTTTACGAAACATAAAC <br />                                                AGTCGGCGGGTGTCGGGGCTGGC-3&#226;&#8364;&#178; ELO3rev: 5&#226;&#8364;&#178;- <br />                                                TAAGCAGCAGCAGCCTGAGTACCATAACAAGTACCCTTGTTTGGTAAAATACCG <br />                                                TCCAAGTTGCCGATTTCGGCCTATT G-3&#226;&#8364;&#178; elo3::TRP1). Verification deletion <br />                                                performed PCR analysis using checking primers. Gene specific oligonucleotides                                                obtained Invitrogen. Disruptions containing kanamycin (G418) resistance marker <br />                                                obtained deletion consortium isolated segregants different crosses. Yeast <br />                                                strains grown YPAD (1% yeast extract, 2% bacto-peptone, 2% glucose, . <br />                                                012% adenine sulfate) synthetic complete media (CSM) containing 0.67% yeast nitrogen <br />                                                base (Difco) supplemented appropriate amino acids. Additional <span id='am-46' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-47' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-49' property="rdfs:label" content="Uracil" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>uracil</span>, (.004%), leucine <br />  <br />  <br />                                                        Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                        Page 3 <br />  <br />  <br />                                                (.02%), histidine (.004%), tryptophan (.01%) supplemented required. CSM <br />                                                lacking specific nutrients used selection various marker genes. Ergosterol,                                                used, added autoclaved media 20 &#206;&#188;g/ml rescue synthetically lethal double mutant <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                strains. anaerobic growth, anaerobic jars containing GasPaks (BBL <br />                                                Microbiology  used. Sporulation media described previously (14).                                                solid media growth yeast contained 2% Bacto Agar (Difco). <br />  <br />                               Genetic methods <br />                                                Mating, sporulation, genetic dissections obtain double triple mutants                                                described previously (14). Crosses asci dissections spore meiotic products                                                YPAD solid media supplemented 20&#206;&#188;g/ml ergosterol Tween 80/ethanol <br />                                                (1:1v/v) solution grown anaerobically. Briefly, diploids grown YPAD medium                                                transferred 1% potassium acetate medium induce sporulation. 1 hr treatment <br />                                                glusulase (Perkin Elmer Life science), spored-asci dissected                                                microscope using micromanipulator. meiotic segregants analyzed replica plating <br />                                                YPAD CSM plates ergosterol synthetic lethal screening                                                genotype confirmed genetic markers. <br />  <br />                               Sterol analysis <br />                                                Sterols isolated described previously (16). Briefly, cells grown 20-24 hrs NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                YPAD liquid solid media containing 20 &#206;&#188;g/ml <span id='am-51' about='obo:IMR_0200486' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-52' property="oboInOwl:id" content="IMR:0200486" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasDbXref" content="KEGG:C00187" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="Cholesterol" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>cholesterol</span>. Cells pelleted, washed <br />                                                twice Igepal (1%), twice distilled H20, saponified alcoholic KOH                                                extracted n-heptane. Sterols preliminarily analyzed gas chromatography (GC)                                                Hewlett-Packard HP5890 series II chromatograph equipped HP CHEMSTATION <br />                                                software package. DB-5 capillary column (15 m &#195;&#8212; 0.25 mm &#195;&#8212; 0.25 &#206;&#188;m film thickness) <br />                                                nitrogen carrier gas (30 cm/sec) programmed 195&#194;&#176; 300&#194;&#176;C (3 min 195&#194;&#176; <br />                                                C increase 5.5&#194;&#176;C/min 300&#194;&#176;C held 10 min). injections                                                run splitless mode inlet temperature 280&#194;&#176;C. order identify novel sterols, <br />                                                gas-chromatography mass-spectrometry (GC-MS) analyses performed using                                                HP5890 GC coupled HP5972 mass selective detector. GC separations                                                fused silica column (DB-5 15 m &#195;&#8212; 0.32 mm &#195;&#8212; 0.25 m film thickness), programmed 40&#194;&#176; <br />                                                C 300&#194;&#176;C (40&#194;&#176;C 1 min, 30&#194;&#176;C/min 300&#194;&#176;C held 4 min). Helium                                                carrier gas linear velocity 50 cm/sec splitless mode. Mass spectra generated <br />                                                electron impact mode electron energy 70 eV <span id='am-23' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-24' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>ion</span> source temperature 150&#194;&#176; <br />                                                C. instrument programmed scan 40 700 amu 1-s intervals. <br />  <br />                               RESULTS <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Synthetic lethality erg2erg24 <br />                                                observations erg2 erg24 mutants suppressed elo2 elo3 <br />                                                mutations observation erg24 lethal genetic backgrounds                                                led ask erg2erg24 double mutant strain viable.                                                erg2erg24 double mutant obtained mating viable erg2 erg24 haploid strains                                                produce diploid heterozygotes; diploids sporulated, spored asci                                                dissected rich medium containing ergosterol  cholesterol) grown anaerobically.                                                total 100 tetrads, 83 erg2erg24 double mutants obtained grow <br />                                                anaerobically sterol supplement failed grow aerobically sterol supplement <br />                                                (table 1). fig. 1, wildtype, erg2, erg24, erg2erg24 strains plated aerobic <br />                                                YPAD rich medium synthetic complete medium (CSM). YPAD medium, erg24 strains <br />                                                grew growth diminished lower inocula; YPAD medium, erg2erg24 growth                                                completely absent.  CSM medium erg2 erg24 strains grew normally                                                erg2erg24 strain demonstrated minimal growth indicating synthetically lethal <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                        Page 4 <br />  <br />  <br />                                                medium. presence ergosterol  requires anaerobic growth conditions                                                sterol uptake) strains grew equally  YPAD CSM media supplemented                                                10 20 mM CaCl2, growth responses calcium. Results NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                20mM CaCl2  shown) exactly 10mM CaCl2 (fig. 1). <br />  <br />                               Suppression erg2erg24 <br />                                                Mutations ELO2 ELO3 known suppressors erg2 erg24 mutants (6,7).                                                generated elo2erg2erg24 elo3erg2erg24 triple mutant strains determine                                                suppressed lethality erg2erg24 strain. Fig. 2 demonstrates elo3 <br />                                                suppressed erg2erg24 lethality YPAD medium indicated growth medium <br />                                                ergosterol.  CSM medium elo2 elo3 efficient <br />                                                suppressor small residual growth medium ergosterol.  <br />                                                CaCl2 supplementation YPAD CSM media did rescue synthetic lethality                                                erg2erg24. <br />  <br />                               Sterol analysis erg2erg24 erg2erg24elo3 <br />                                                proceeded determine sterol composition strains assess                                                sterol composition difference attributable suppressed erg2erg24elo3 strain. <br />                                                Table 2 indicates sterol composition wildtype, elo3, erg2, erg24, erg2erg24, <br />                                                erg2elo3, erg24elol3, suppressed erg2erg24elo3 strains grown YPAD media NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                aerobic conditions. Identification sterols based molecular ions key fragment ions <br />                                                comparison standard sterol spectra relative retention times (Table 3).                                                erg2erg24 strain grown anaerobically presence cholesterol. essentially <br />                                                difference sterol profiles wildtype elo3strains. erg2erg24 strain <br />                                                accumulated ergosta-8,14-diene sterols <span id='am-36' about='obo:IMR_0200481' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-37' property="rdfs:label" content="Squalene" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasDbXref" content="KEGG:C00751" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:id" content="IMR:0200481" datatype="xsd:string"></span>squalene</span>, lanosterol, cholesterol <br />                                                provided growth medium. Sterol profiles erg24 erg2erg24elo3 <br />                                                strains similar 94% 99% sterols accumulated strains <br />                                                ergosta-8,14, cholesta-8,14 sterols, respectively, suggesting major effect                                                elo3 suppression did involve alteration sterols.  erg2elo3                                                erg24elo3 reflected sterol compositions erg2 erg24, respectively. <br />  <br />                               Synthetic lethality erg24 combination ergosterol biosynthetic mutants. <br />                                                ascertain ergosterol mutations erg3, erg4, erg5, <br />                                                erg6, erg28 synthetically lethal combination erg24 mutation. <br />                                                ERG3 encodes C-5 desaturase, ERG4 encodes C-24 reductase, ERG5 encodes C-22 <br />                                                desaturase, ERG6 encodes C-24 transmethylase; mutations genes viable (fig. <br />                                                3B). ERG28 encodes scaffold protein required complete C-4 demethylation   <br />                                                non-essential growth. crossed single mutants erg24 strain generate NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                haploid double mutants. tetrads dissected grown anaerobically ergosterol <br />                                                grown aerobically ergosterol assess viability (fig.3). Genetic analyses (table <br />                                                1) spot-plating (fig.3) YPAD medium demonstrated double mutant <br />                                                erg4erg24 erg5erg24 viable erg6erg24 erg28erg24 double mutants                                                  erg3erg24 double mutants weakly viable. addition CaCl2 <br />                                                growth enhancing effect erg5erg24 YPAD medium CSM medium;                                                CSM medium, CaCl2 growth enhancing effect erg6erg24 erg28erg24. <br />                                                Finally, elo3 failed suppress erg6erg24 erg28erg24 YPAD CSM media (data                                                shown). observation elo3 did suppress erg6erg24 expected Eisenkolb et al. <br />                                                (17) demonstrated double mutant elo3erg6 synthetically lethal. <br />  <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                          Page 5 <br />  <br />  <br />                               DISCUSSION <br />                                                genes yeast ergosterol pathway comprised ERG6, ERG2, ERG3, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                ERG4, ERG5 considered non-essential sterols produced mutations                                                genes function nearly ergosterol meet biophysical biochemical <br />                                                requirements sterol molecule.  mutations ERG24 lethal genetic <br />                                                backgrounds  <br />  <br />                                                results presented extend initial observations viability erg24 dependent <br />                                                factors type media, metal ion concentrations, strain background. Studies                                                Parks&#226;&#8364;&#8482; lab (8,9) indicated erg24 grow rich media (YPAD) grow <br />                                                synthetic complete media greater abundance Ca+2  Addition                                                Ca+2 rich medium restored growth. studies confirm findings differ                                                deletion consortium erg24 strain viable YPAD medium growth enhanced <br />                                                addition Ca+2 (fig.1). growth enhanced CSM medium.                                                combination erg2 erg24,  resulted lethality YPAD medium                                                rescued Ca+2 supplementation. Growth erg2erg24 strain marginal synthetic <br />                                                complete medium. Suppression lethality obtained introducing mutation, <br />                                                elo3. elo3 mutation previously individually suppress lethal isolates erg2 <br />                                                erg24.  elo3 able restore growth erg2erg24 strain YPAD <br />                                                medium, failed restore growth CSM medium (fig. 2). Surprisingly elo2 failed NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                suppress lethality erg2erg24 media, media containing Ca+2 <br />                                                supplementation. <br />  <br />                                                asked question ergosterol mutants lethal combination                                                erg24 results indicated erg6erg24 erg28erg24 inviable rich <br />                                                YPAD medium lack growth suppressed Ca+2 supplementation.                                                double mutant erg3erg24 grew poorly erg4erg24 lesser extent <br />                                                erg5erg24was clearly growing YPAD.  synthetic complete medium,                                                observed slightly better growth presence Ca+2 (fig.3). double mutants grew                                                degree synthetic complete medium Ca+2 added medium. <br />  <br />                                                Crowley et al. (9) demonstrated concentration Ca+2 greater synthetic <br />                                                complete rich YPD medium increased Ca+2 resulted resistance                                                fenpropimorph suggesting Ca+2 enhances membrane integrity strains                                                ergosterol replaced ergosta-8,14 sterol intermediates. obvious erg2erg24 <br />                                                mutants compromised erg24 erg24 mutants epistatic erg2                                                accumulate C-8 sterols.  erg24 strain evidence Erg2p activity <br />                                                accumulated sterols C-8-sterols. work determine NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                regulatory sterol defect taken consideration.  considering                                                synthetically lethality erg6erg24 erg28erg24 strains, individual mutation                                                contribute altered sterol profile help explain double mutants                                                cases lethal. <br />  <br />                               ACKNOWLEDGEMENTS <br />                                                work supported NIH grant GM62104 M.B. <br />  <br />  <br />                               LITERATURE CITED <br />                                                1. Lorenz RT, Parks LW. Cloning, Sequencing, Disruption Gene Encoding Sterol C-14 <br />                                                   Reductase Saccharomyces cerevisiae. DNA Cell Biol 1992;11:685&#226;&#8364;&#8220;692. [PubMed: 1418625] <br />                                                2. Marcireau C, Guyonnet D, Karst F. Construction Growth Properties Yeast Strain Defective <br />                                                   Sterol 14-Reductase. Curr. Genet 1992;22:267&#226;&#8364;&#8220;272. [PubMed: 1394506] <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                              Page 6 <br />  <br />  <br />                                                3. Oh CS, Toke DA, Mandala S, Martin CE. ELO2 ELO3, Homologues Saccharomyces <br />                                                   Cerevisiae ELO1 Gene, Function Fatty Acid Elongation Required Sphingolipid <br />                                                   Formation. J. Biol. Chem 1997;272:17376&#226;&#8364;&#8220;17384. [PubMed: 9211877] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                4. Mercer EI. Inhibitors Sterol Biosynthesis Applications. Prog. <span id='am-17' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-18' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span><span id='am-19' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="lipid" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>Lipid</span> Res 1993;32:357&#226;&#8364;&#8220; <br />                                                   416. [PubMed: 8309949] <br />                                                5. Baloch RI, Mercer EI. Inhibition Sterol &#206;&#8221;8-&#206;&#8221;7 Isomerase &#206;&#8221;14 Reductase Fenpropiomorph, <br />                                                   Tridemorph, Fenpropidin Cell-free Enzyme Systems Saccharomyces cerevisiae. <br />                                                   Phytochem 1987;26:663&#226;&#8364;&#8220;668. <br />                                                6. Ladeveze V, Marcireau C, Delourme D, Karst F. General Resistance Sterol Biosynthesis Inhibitors <br />                                                   Saccharomyces cerevisiae. Lipids 1993;28:907&#226;&#8364;&#8220;912. [PubMed: 8246690] <br />                                                7. Baudry K, Swain E, Rahier  Germann M, Batta  Rondet S, Mandala S, Henry K, Tint GS, Edlind <br />                                                   T, Kurtz M, Nickels JT. Effect Erg26-1 Mutation Regulation Lipid Metabolism <br />                                                   Saccharomyces cerevisiae. J. Biol. Chem 2001;276:12702&#226;&#8364;&#8220;12711. [PubMed: 11279045] <br />                                                8. Crowley JH, Smith SJ, Leak FW, Parks LW. Aerobic Isolation ERG24 Null Mutant                                                   Saccharomyces cerevisiae. J. Bacteriol 1996;178:2991&#226;&#8364;&#8220;2993. [PubMed: 8631695] <br />                                                9. Crowley JH, Tove S, Parks LW. Calcium-Dependent Ergosterol Mutant Saccharomyces <br />                                                   cerevisiae. Curr. Genet 1998;34:93&#226;&#8364;&#8220;99. [PubMed: 9724410] <br />                                                10. Lai MH, Bard M, Pierson CA, Alexander JF, Goebl M, Carter GT, Kirsch DR. Identification                                                     Gene Family Saccharomyces Cerevisiae Ergosterol Biosynthesis Pathway. Gene <br />                                                     1994;11:41&#226;&#8364;&#8220;49. [PubMed: 8125337] <br />                                                11. Silve S, Leplatois P, Josse  Dupuy PH, Lanau C, Kaghad M, Dhers C, Picard C, Rahier  Taton <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     M, Le Fur G, Caput D, Ferrara P, Loison G. Immunosuppressant SR 31747 Blocks Cell <br />                                                     Proliferation Inhibiting Steroid Isomerase Saccharomyces cerevisiae. Mol. Cell. Biol <br />                                                     1996;16:2719&#226;&#8364;&#8220;2727. [PubMed: 8649379] <br />                                                12. Winzeler EA, et al. Functional Characterization S. Cerevisiae Genome Gene Deletion                                                     Parallel Analysis. Science 1999;6:901&#226;&#8364;&#8220;906. [PubMed: 10436161] <br />                                                13. Valachovic M, Bareither BM, Bhuiyan MSA, Eckstein J, Barbuch R, Balderes D, Wilcox L, Sturley <br />                                                     SL, Dickson RC, Bard M. Cumulative Mutations Affecting Sterol Biosynthesis Yeast <br />                                                     Saccharomyces cerevisiae Result Synthetic Lethality Suppressed Alterations                                                     Sphingolipid Profiles. Genetics. 2006In Press <br />                                                14. Adams, ; Gottschling, ; Kaiser, CA.; Stearns, T. Methods Yeast Genetics. Cold Spring Harbor <br />                                                     Laboratory Press; New York, N.Y: 1997. <br />                                                15. Sikorski RS, Hieter P. Shuttle Vectors Yeast Host Strains Designed Efficient <br />                                                     Manipulation DNA Saccharomyces cerevisiae. Genetics 1989;122:19&#226;&#8364;&#8220;27. [PubMed: 2659436] <br />                                                16. Gachotte D, Sen SE, Eckstein J, Barbuch R, Krieger M, Ray BD, Bard M. Characterization                                                     Saccharomyces cerevisiae ERG27 Gene Encoding 3-Keto Reductase Involved C-4 Sterol <br />                                                     Demethylation. Proc Natl Acad Sci USA 1999;26:12655&#226;&#8364;&#8220;12660. [PubMed: 10535978] <br />                                                17. Eisenkolb M, Zenzmaier C, Leitner E, Schneiter R. specific structural requirement ergosterol <br />                                                     long-chain fatty acid synthesis mutants important maintaining raft domains yeast. Mol Biol <br />                                                     Cell. 13:4414&#226;&#8364;&#8220;4428. [PubMed: 12475962] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                    Page 7 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Fig.1. <br />                                                Synthetically lethality erg2erg24 double mutant strain. Cells serially diluted                                                105 102 cells sequentially spotted YPAD (upper panels) CSM (lower panels) <br />                                                media ergosterol 10 mM CaCl2 compare phenotype strains. <br />                                                strains tested wild type, erg2, erg24, erg2erg24. Plates containing ergosterol <br />                                                incubated anaerobically ergosterol aerobically 3 days 30&#194;&#176;C.                                                erg2erg24 double mutant strain able grow presence ergosterol. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                    Page 8 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Fig.2. <br />                                                mutation elo3 elo2 mutation suppresses erg2erg24 double mutant.                                                growth response strains elo2, erg2erg24elo2, elo3, erg2erg24elo3 compared                                                spotting serial dilutions 105 102 cells strain YPAD (upper panels) CSM <br />                                                (lower panels) media ergosterol 10 mM CaCl2. Plates containing <br />                                                ergosterol incubated anaerobically ergosterol aerobically 3 days                                                30&#194;&#176;C. erg2erg24elo3 triple mutant strain able grow YPAD CSM <br />                                                media ergosterol 10 mM CaCl2. erg2erg24elo2 triple mutant strain NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                unable grow YPAD poorly CSM media. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                             Shah Alam Bhuiyan et al.                                                                                    Page 9 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Fig.3. <br />                                                erg24 mutation synthetically lethal erg6 erg28 erg3, erg4, erg5. <br />                                                  Growth erg24 mutant combination additional mutations ergosterol <br />                                                biosynthetic pathway-erg3, erg4, erg5, erg6, erg28. Cells double mutants                                                serially spotted YPAD (upper panels) CSM (lower panels) media                                                ergosterol 10 mM CaCl2. Plates containing ergosterol incubated anaerobically <br />                                                ergosterol aerobically 3 days 30&#194;&#176;C. erg6erg24 erg28erg24 <br />                                                mutant strains did grow YPAD medium ergosterol; erg3erg24                                                erg5erg24 mutant strains grew poorly; erg4erg24 mutant strain grew  strains <br />                                                grew poorly poorly CSM media ergosterol 10 mM CaCl2. (B) erg3, <br />                                                erg4, erg5, erg6, erg28 single mutant strains viable YPAD CSM media <br />                                                ergosterol. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                         Lipids. Author manuscript; available PMC 2007 April 5. <br />                                 Shah Alam Bhuiyan et al.                                                                                          Page 10 <br />  <br />                                                                                                  Table 1 <br />                                Genetic analysis determine synthetic lethality erg24 double mutants YPAD medium. <br />  <br />                                     Mating                       Tetrads Disected                   Viable Double Mutantsa   Inviable Double Mutantsa <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                   erg2 x erg24                          100                                     0                      83 <br />                                   erg3 x erg24                           20                                   17b                       0 <br />                                   erg4 x erg24                           14                                    14                       0 <br />                                   erg5 x erg24                           22                                   18b                       0 <br />                                   erg6 x erg24                           13                                     0                      13 <br />                                  erg28 x erg24                           21                                     0                      16 <br />  <br />                                                        double mutants erg24 combination erg2,erg3,erg4,erg5,erg6 erg28 <br />                            b <br />                             poorly viable <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                 Lipids. Author manuscript; available PMC 2007 April 5. <br />                                 Shah Alam Bhuiyan et al.                                                                                                      Page 11 <br />  <br />                                                                                                  Table 2 <br />                                Sterol analyses erg2erg24, erg2erg24elo3, related strains <br />  <br />                                                                                                                       Percent Sterol <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Sterol                     Wild type           elo3      erg2       erg24         erg2         erg2 elo3   erg24 elo3          erg2 erg24 elo3 <br />                                                                                                                          erg24a <br />  <br />                            Squalene                                    0.27            0.98        -         5.58        28.04             -         0.82                   0.78 <br />                            Cholesterol                                   -               -         -           -         47.84             -           -                      - <br />                            Ergosta-5,8,22,24 (28) tetraen-3-             -               -       1.88          -           -               -           -                      - <br />                            ol <br />                            Zymosterol                                 18.73           18.46      1.30          -              -            -           -                      - <br />                            Ergosterol                                 61.30           56.98        -           -              -            -           -                      - <br />                            Ergosta-7,22 dien-3-ol                      2.43            2.53        -           -              -            -           -                      - <br />                            Ergosta-5,7,22,24 (28) tetraen-3-           1.59            1.97        -           -              -            -           -                      - <br />                            ol <br />                            Ergosta- 8,14,24 (28) trien-3-ol              -               -         -        25.20          -              -          40.50                 26.67 <br />                            Ergosta-5.8,22-trien-3-ol                     -               -       31.31         -           -            38.67                                - <br />                            Ergosta-8,14 dien-ol                          -               -                  56.44        14.00            -          37.51                 63.40 <br />                            Ergosta-8 3-ol                             -               -       11.21         -           -            17.05          -                     - <br />                            Fecosterol                                  6.93            7.67      51.55         -           -            37.31          -                     - <br />                            Ergosta-8,14-dien-3                       -               -          -        1.85          -              -            -                     - <br />                            Episterol                                   6.12          <br /> </body></html>